Predictive value of mid luteal progesterone concentration before luteal support in controlled ovarian hyperstimulation with intrauterine insemination

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 44, Issue 1, 2004, Pages 51-56

  Costello, Michael F ^a,b   Emerson, Sandra ^a   Lukic, Julie ^a   Sjoblom, Peter ^a,b   Garrett, Don ^a,b   Hughes, Graeme ^a,b   Steigrad, Stephen ^a  

^a Dept of Reproductive Medicine/IVF ^*  (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Intrauterine insemination; Mid luteal; Ovulation induction; Pregnancy; Progesterone

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; ENDOMETRIOSIS; FEMALE; HOSPITAL DEPARTMENT; HUMAN; INTRAUTERINE INSEMINATION; LUTEAL PHASE; MAJOR CLINICAL STUDY; MALE INFERTILITY; OVARY HYPERSTIMULATION; PREDICTION; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RANK SUM TEST; RETROSPECTIVE STUDY; TREATMENT FAILURE; ULTRASOUND;

ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFERTILITY, FEMALE; INSEMINATION, ARTIFICIAL; LUTEAL PHASE; OVARIAN HYPERSTIMULATION SYNDROME; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROBABILITY; PROGESTERONE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 1242330872     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2004.00160.x     Document Type: Article

References (24)

1. Templeton A, Fraser C, Thompson B. The epidemiology of infertility in Aberdeen. BMJ. 1990; 301: 148-152.
2. Gregoriou O, Vitoratos N, Papadias C, Konidaris S, Gargaropoulos A, Louridas C. Controlled ovarian hyperstimulation with or without intrauterine insemination for the treatment of unexplained infertility. Int J Gynaecol Obstet. 1995; 48: 55-59.
3. Cohlen BJ, Vandekerckhove P, te Velde ER, Habbema JDF. Timed intercourse versus intra-uterine insemination with or without ovarian hyperstimulation for subfertility in men (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2003.
4. Tummon IS, Asher LJ, Martin JSB, Tulandi T. Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis. Fertil Steril. 1997; 68: 8-12.
5. Homburg R, Insler V. Ovulation induction in perspective. Hum Reprod Update. 2002; 8: 449-462.
6. Graham JD, Clarke CL. Physiological action of progesterone in target tissues. Endocr Rev. 1997; 18: 502-519.
7. Kaplan PF, Katz SL, Thompson AK, Freund RD. Cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination. Influence of the number of mature follicles at hCG administration. J Reprod Med. 2002; 47: 535-539.
8. Stone BA, Vargyas JM, Ringler GE, Stein AL, Marrs RP. Determinants of the outcome of intrauterine insemination. Analysis of outcomes of 9963 consecutive cycles. Am J Obstet Gynecol. 1999; 180: 1522-1534.
9. Norwitz ER, Schust DJ, Fisher SJ. Implantation and the survival of early pregnancy. N Engl J Med. 2001; 345: 1400-1408.
10. World Health Organization. Laboratory Manual for the Examination of Human Semen and Sperm - Cervical Mucus Interaction. Cambridge: Cambridge University Press, 1999.
11. American Fertility Society. Revised American Fertility Society classification of endometriosis. Fertil Steril. 1985; 43: 351-352.
12. Ellenbogen A, David H, Libal Y, Ballas S. Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins. Harefuah. 1995; 129: 455-456.
13. Maclin VM, Radwanska E, Binor Z, Dmowski WP. Progesteron: estradiol ratios at implantation in ongoing pregnancies, abortions, and nonconception cycles resulting from ovulation induction. Fertil Steril. 1990; 54: 238-243.
14. Laufer N, Navot D, Schenker JG. The pattern of luteal phase progesterone and estradiol in fertile cycles. Am J Obstet Gynecol. 1982; 143: 808-813.
15. Dlugi AM, Laufer N, deCherney AH et al. The periovulatory and luteal phase of conception cycles following in vitro fertilization and embryo transfer. Fertil Steril. 1984; 41: 530-537.
16. Hassiakos D, Toner JP, Muasher SJ, Jones HW Jr. Implantation and pregnancy rates in relation to oestradiol and progesterone profiles in cycles with and without the use of gonadotrophin-releasing hormone agonist suppression. Hum Reprod. 1990; 5: 1004-1008.
17. Vicdan K, Isik ZA. Luteal phase hormonal profile in prediction of pregnancy outcome after assisted reproduction. Eur J Obstet Gynaecol Reprod Biol. 2001; 96: 98-101.
18. Abraham GE, Maroulis GB, Marshall JR. Evaluation of ovulation and corpus luteum function using measurements of plasma progesterone. Obstet Gynecol. 1974; 44: 522-525.
19. Balasch J, Creus M, Fabregues F et al. Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support. Gynecol Endocrinol. 1995; 9: 51-58.
20. Macklon NS, Geraedts JPM, Fauser BCJM. Conception to ongoing pregnancy: the 'black box' of early pregnancy loss. Hum Reprod Update. 2002; 8: 333-343.
21. Speroff L, Glass RH, Kase NG. Clinical Gynaecologic Endocrinology and Infertility, 6th edn. Baltimore: Lippincott Williams & Wilkins, 1999.
22. Kolb BA, Paulson RJ. The luteal phase of cycles utilizing controlled ovarian hyperstimulation and the possible impact of this hyperstimulation on embryo implantation. Am J Obstet Gynecol. 1997; 176: 1262-1269.
23. Hull MG, Savage PE, Bromham DR, Ismail AA, Morris AF. The value of a single serum progesterone measurement in the mid luteal phase as a criterion of a potentially fertile cycle ('ovulation') derived from treated and untreated conception cycles. Fertil Steril. 1982; 37: 355-360.
24. Sallam HN, Sallam A, Ezzeldin F, Agamia AF, Abou-Ali A. Reference values for the mid luteal plasma progesterone concentration: evidence from human menopausal gonadotropin-stimulated pregnancy cycles. Fertil Steril. 1999; 71: 711-714.